Economic Burden of Pancreatic Cancer in Europe: a Literature Review
ConclusionPancreatic cancer direct costs PPM are in the upper bound relative to other cancer types; however, direct per patient costs are likely to be lower because of shorter survival. Indirect costs are substantial, mainly attributed to high mortality.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Pancreas | Pancreatic Cancer | Science | Study